首页> 外文期刊>Cancer Medicine >Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database?¢????Breast Cancer Registry
【24h】

Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database?¢????Breast Cancer Registry

机译:浸润性乳腺癌诊断后的体重指数和生存率:基于日本国家临床数据库的研究-乳腺癌注册中心

获取原文
获取外文期刊封面目录资料

摘要

Abstract Few studies have reported the association between body mass index (BMI) and outcome among Asian breast cancer patients. We analyzed data for 20,090 female invasive breast cancer patients who had been followed-up for a median period of 6.7 years entered in the National Clinical Database?¢????Breast Cancer Registry between 2004 and 2006. We used mainly the WHO criteria for BMI (kg/m 2 ) categories; <18.5 (underweight), ?¢???¥18.5?¢????<21.8 (reference), ?¢???¥21.8?¢????<25, ?¢???¥25?¢????<30 (overweight), and ?¢???¥30 (obese). We divided normal weight patients into two subgroups because this category includes many patients compared to others. The timing of BMI measurement was not specified. The Cox proportional hazards model and cubic spline regression were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Smoking, alcohol, and physical activity were not controlled. A total of 1418 all-cause, 937 breast cancer?¢????specific deaths, and 2433 recurrences were observed. Obesity was associated with an increased risk of all-cause (HR: 1.46; 95% CI: 1.16?¢????1.83) and breast cancer?¢????specific death (HR: 1.47; 95% CI: 1.11?¢????1.93) for all patients, and with all-cause (HR: 1.47; 95% CI: 1.13?¢????1.92) and breast cancer?¢????specific death (HR: 1.58; 95% CI: 1.13?¢????2.20) for postmenopausal patients. Being underweight was associated with an increased risk of all-cause death for all (HR: 1.41; 95% CI: 1.16?¢????1.71) and for postmenopausal patients (HR: 1.45; 95% CI: 1.15?¢????1.84). With regard to subtype and menopausal status, obesity was associated with an increased risk of breast cancer?¢????specific death for all cases of luminal B tumor (HR: 2.59; 95% CI: 1.51?¢????4.43; P heterogeneity of Luminal B vs. Triple negative = 0.016) and for postmenopausal patients with luminal B tumor (HR: 3.24; 95% CI: 1.71?¢????6.17). Being obese or underweight is associated with a higher risk of death among female breast cancer patients in Japan.
机译:摘要很少有研究报道亚洲乳腺癌患者的体重指数(BMI)与预后之间的相关性。我们分析了2004年至2006年之间进入国家临床数据库(National Clinical Database)的20 090名中位随访时间为6.7年的女性浸润性乳腺癌患者的数据。我们主要使用WHO的标准体重指数(kg / m 2)类别; <18.5(体重不足),118.5 ¢ ??? <21.8(参考),¢ 21.8 ¢ 2 25,¢ 25 ¢ <30(超重),30日元(肥胖)。我们将体重正常的患者分为两个亚组,因为与其他患者相比,该类别包括许多患者。未指定BMI测量的时间。使用Cox比例风险模型和三次样条回归来估计风险比(HRs)和95%置信区间(CIs)。吸烟,饮酒和体育锻炼不受控制。总共观察到1418例全因,937例乳腺癌特异性死亡和2433例复发。肥胖与全因(HR:1.46; 95%CI:1.16?1.83)和乳腺癌的特异性死亡风险增加(HR:1.47; 95%CI:1.11)相关。 1.93)适用于所有患者,并包括全因(HR:1.47; 95%CI:1.13 1.92)和乳腺癌特异性死亡(HR:1.58) ;对于绝经后患者,95%CI:1.13≤2.20)。体重过轻与全因死亡(HR:1.41; 95%CI:1.16?1.71)和绝经后患者(HR:1.45; 95%CI:1.15)有关。 1.84)。关于亚型和更年期状态,肥胖与所有管腔B型肿瘤病例的特定死亡风险增加有关(HR:2.59; 95%CI:1.51?4.43)。 ; Luminal B的P异质性vs. Triple阴性= 0.016)以及绝经后患有Luminal B肿瘤的患者的P异质性(HR:3.24; 95%CI:1.71 ¢ 6.17)。肥胖或体重不足与日本女性乳腺癌患者较高的死亡风险相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号